Publications by authors named "Warren Heller"

Claim this Profile
G
Gatifloxacin 0.5% administered twice daily for the treatment of acute bacterial conjunctivitis in patients one year of age or older.
Warren Heller, Marilou Cruz, Yasmin Rusi Bhagat, Jesse M De Leon, Carlos Felix

J Ocul Pharmacol Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.
Steven J Lichtenstein, Liberation De Leon, Warren Heller, Bonnie Marshall, Gale Cupp

J Pediatr Ophthalmol Strabismus· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.
Run Wang, Arthur L Burnett, Warren H Heller, Kenji Omori, Jun Kotera

J Sex Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.
Michael E Tepedino, Warren H Heller, Dale W Usner, Lynne S Brunner, Timothy W Morris

Curr Med Res Opin· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Mark B Abelson, Warren Heller, Aron M Shapiro, Erwin Si, Peng Hsu

Am J Ophthalmol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis